Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D08UNQ
|
|||
| Former ID |
DIB002282
|
|||
| Drug Name |
NSD-644
|
|||
| Synonyms |
Serotonin/noradrenaline/dopamine activator (pain, depression, CNS disorder), NeuroSearch
Click to Show/Hide
|
|||
| Indication | Neurological disorder [ICD-11: 6B60] | Discontinued in Phase 1 | [1] | |
| Company |
NeuroSearch A/S
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800027571) | |||
| REF 2 | NSD-644: Phase I started.NeuroSearch A/S (CSE:NEUR), Ballerup, Denmark, GlaxoSmithKline plc (LSE:GSK; GSK), London, U.K. | |||
| REF 3 | Clinical pipeline report, company report or official report of Neurosearch. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.